What do people with intellectual disabilities, their family members and paid carers understand about psychotropic medication? A rapid review

Background People with intellectual disabilities are more likely to be prescribed psychotropic medication than the general population and are frequently prescribed multiple medications. Understanding people with intellectual disabilities and carer perspectives is essential to improving the quality o...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of applied research in intellectual disabilities Vol. 37; no. 5; pp. e13283 - n/a
Main Authors:	Cavanagh, Dawn E., Caton, Sue, Rawles, Jodie, Runswick‐Cole, Katherine, Hatton, Chris, Chauhan, Umesh, Hutchinson, Christine
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Publishing Ltd 01-09-2024 Wiley Subscription Services, Inc
Subjects:	behaviours that challenge Caregivers Drug use Families & family life Family family members Health Knowledge, Attitudes, Practice Humans Intellectual disabilities Intellectual Disability - drug therapy Knowledge paid carers Prescription drugs Psychotropic drugs Psychotropic Drugs - therapeutic use psychotropic medication Support personnel understanding family members understanding intellectual disabilities paid carers behaviours that challenge psychotropic medication
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Background People with intellectual disabilities are more likely to be prescribed psychotropic medication than the general population and are frequently prescribed multiple medications. Understanding people with intellectual disabilities and carer perspectives is essential to improving the quality of psychotropic medication prescribing and usage. Method A rapid review explored people with intellectual disabilities' understanding of psychotropic medications, as well as family members and paid carers, and how this understanding can be improved. Results Twenty‐one journal articles were included. Lack of understanding of medication was universal, with participants often unaware of adverse effects, alternatives, and rights around medication. There was also a lack of involvement in decision making for all participants. Some interventions aimed at people with intellectual disabilities or paid carers helped to improve knowledge. Conclusion Evaluating how best to improve psychotropic medication understanding for people with intellectual disabilities, family members and paid carers should be a focus for future research.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
ISSN:	1360-2322 1468-3148 1468-3148
DOI:	10.1111/jar.13283